Asia Pacific HIV Diagnostics Market will grow at highest pace owing to increasing HIV prevalence

Comments · 78 Views

The Asia Pacific HIV Diagnostics Market consists of diagnostic tests for the detection of antibodies and antigens associated with HIV. Growing demand for minimally-invasive, accurate, and early screening is fueling the adoption of advanced rapid point-of-care diagnostic tests for HIV/AIDS

The Asia Pacific HIV diagnostics market consists of products such as consumables, equipment and software used for screening and diagnosis of HIV disease. HIV diagnostics help in early detection of the virus, which enables prompt treatment and management of the disease. Growing prevalence of HIV across developing nations, rising awareness initiatives by governments and NGOs, and increasing healthcare expenditures are some of the key factors driving the demand for HIV diagnostic products in the Asia Pacific region.

Asia Pacific HIV Diagnostics Market is estimated to be valued at US$ 522.5 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030.

Key Takeaways
Key players operating in the Asia Pacific HIV diagnostics are Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo Diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation. The rising disease prevalence coupled with increasing screening initiatives is expected to boost the demand for HIV diagnostic products in Asia Pacific region. Furthermore, technological advancements such as development of user-friendly and portable diagnostics will further support the market growth over the coming years.

Market trends
Some of the key trends witnessed in the Asia Pacific HIV diagnostics market include increasing adoption of rapid test kits owing to advantages such as ease of use and quick results. There is also a rising focus on point-of-care HIV diagnostic devices due to benefits such as reduced turn-around time and on-site testing.

Market Opportunities
The untapped rural markets in developing nations offer major growth opportunities for players in this market. Launch of affordable and less invasive testing technologies also present lucrative opportunities.Development of novel screening and confirmatory testswith high sensitivity and accuracy will further aid the market expansion.

Impact of COVID-19 on Asia Pacific HIV Diagnostics Market
The COVID-19 pandemic has impacted the growth of Asia Pacific HIV Diagnostics market. During the initial phase of pandemic in 2020, clinics and hospitals were focused on tackling COVID cases which reduced the number of HIV tests being conducted. This further delayed the diagnosis of new HIV cases. However, with increasing awareness, some governments promoted home-based and community-based HIV testing to minimize hospital visits and reduce the risk of COVID exposure. Telehealth and teleconsultation also gained prominence for management of HIV patients. Post pandemic, as restrictions eased, testing volumes increased but the demand is yet to recover to pre-pandemic levels fully. Going forward, market players need to promote affordable and scalable testing options to boost screening, generate awareness about safe testing during pandemic, and ensure continuity of care for known HIV patients through telemedicine and home delivery of medicines.

The value concentration of Asia Pacific HIV Diagnostics market in terms of geography is highest in China, India, Indonesia and Vietnam. China accounted for over 35% of the total market value in 2024 due to large population, rising healthcare investments and policy support for HIV screening. India is the second largest HIV diagnostics market in Asia Pacific driven by government initiatives and efforts to eliminate new infections by 2030. The fastest growing region for this market during 2023-2030 forecast period is expected to be Southeast Asian countries like Indonesia and Vietnam due to rising awareness, growing healthcare access and increasing cooperation for HIV control programs in the region.

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

 (LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/

Comments